413 related articles for article (PubMed ID: 6497193)
1. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of a long-acting injectable form of bromocriptine in patients with prolactin and growth hormone secreting macroadenomas.
Tsagarakis S; Tsiganou E; Tzavara I; Nikolou H; Thalassinos N
Clin Endocrinol (Oxf); 1995 Jun; 42(6):593-9. PubMed ID: 7634499
[TBL] [Abstract][Full Text] [Related]
3. Invasive mixed growth hormone/prolactin secreting pituitary tumour: complete shrinking by octreotide and bromocriptine, and lack of tumour growth relapse 20 months after octreotide withdrawal.
Sadoul JL; Thyss A; Freychet P
Acta Endocrinol (Copenh); 1992 Feb; 126(2):179-83. PubMed ID: 1543025
[TBL] [Abstract][Full Text] [Related]
4. Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study.
Bergström M; Muhr C; Lundberg PO; Bergström K; Gee AD; Fasth KJ; Långström B
J Comput Assist Tomogr; 1987; 11(5):815-9. PubMed ID: 3498743
[TBL] [Abstract][Full Text] [Related]
5. Parenteral bromocriptine in the treatment of hormonally active pituitary tumours.
Benker G; Gieshoff B; Freundlieb O; Windeck R; Schulte HM; Lancranjan I; Reinwein D
Clin Endocrinol (Oxf); 1986 May; 24(5):505-13. PubMed ID: 3791649
[TBL] [Abstract][Full Text] [Related]
6. Bromocriptine-induced changes in hormone secretion and cell morphology in growth hormone and prolactin producing pituitary adenomas.
Anniko M; Werner S; Wersäll J
Acta Otolaryngol; 1981; 92(3-4):343-55. PubMed ID: 7324902
[No Abstract] [Full Text] [Related]
7. Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
Goodman LA; Chang RJ
Obstet Gynecol; 1984 Sep; 64(3 Suppl):2S-7S. PubMed ID: 6433250
[TBL] [Abstract][Full Text] [Related]
8. [Primary hyperprolactinemic amenorrhea. Report of 4 patients].
Rudolf K; Smid I; Kunkel S; Bazsa-Kassai Z
Zentralbl Gynakol; 1985; 107(14):894-8. PubMed ID: 3929499
[TBL] [Abstract][Full Text] [Related]
9. Bromocriptine in the management of infertile men after surgery of prolactin secreting adenomas.
Mancini A; Guitelman A; Levalle O; Aparicio N; Aszenmil G
J Androl; 1984; 5(4):294-6. PubMed ID: 6432759
[TBL] [Abstract][Full Text] [Related]
10. Serum gonadotrophin pulsatile secretion in men with Prl-secreting and non-secreting pituitary tumours.
Ambrosi B; Giovine C; Nava C; Elli R; Faglia G
Acta Endocrinol (Copenh); 1985 May; 109(1):1-6. PubMed ID: 3923752
[TBL] [Abstract][Full Text] [Related]
11. Effects of naloxone on prolactin-secreting pituitary adenomas.
Shima K; Chigasaki H; Seki K
Neurol Med Chir (Tokyo); 1990 Feb; 30(2):109-12. PubMed ID: 1695330
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with bromocriptine of a plurihormonal pituitary adenoma secreting thyrotropin, growth hormone and prolactin.
Shimatsu A; Murabe H; Nakamura Y; Mizuta H; Ihara C; Nakao K
Endocr J; 1999 Feb; 46(1):159-65. PubMed ID: 10426581
[TBL] [Abstract][Full Text] [Related]
13. Bromocriptine reduces the size of cells in prolactin-secreting pituitary adenomas.
Landolt AM; Minder H; Osterwalder V; Landolt TA
Experientia; 1983 Jun; 39(6):625-6. PubMed ID: 6852202
[TBL] [Abstract][Full Text] [Related]
14. Enlargement of a prolactin-secreting pituitary microadenoma during bromocriptine treatment. Case report.
Crosignani PG; Mattei A; Ferrari C; Giovanelli MA
Br J Obstet Gynaecol; 1982 Feb; 89(2):169-70. PubMed ID: 7066250
[TBL] [Abstract][Full Text] [Related]
15. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Teramoto A; Sanno N; Tahara S; Osamura YR
Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
[TBL] [Abstract][Full Text] [Related]
16. Resolution of possible paradoxical responses of gonadotropins to thyrotropin-releasing hormone with bromocriptine therapy in a patient with follicle-stimulating hormone-secreting pituitary adenoma.
Mercado-Asis LB; Yasuda K; Ishizawa M; Ishizuka T; Murayama M; Shimokawa K; Miura K
Endocrinol Jpn; 1992 Aug; 39(4):401-6. PubMed ID: 1446655
[TBL] [Abstract][Full Text] [Related]
17. A giant prolactinoma and the effect of chronic bromocriptine therapy on basal and TRH-stimulated serum prolactin levels.
Barrera CM; Ruiz AE; Banks WA
Horm Res; 1991; 35(3-4):167-9. PubMed ID: 1806471
[TBL] [Abstract][Full Text] [Related]
18. Bromocriptine treatment of prolactin secreting macroadenomas: a radiological, ophthalmological and endocrinological study.
van 't Verlaat JW; Croughs RJ; Hendriks MJ; Bosma NJ; Nortier JW; Thijssen JH
Acta Endocrinol (Copenh); 1986 Aug; 112(4):487-93. PubMed ID: 3751462
[TBL] [Abstract][Full Text] [Related]
19. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study.
Molitch ME; Elton RL; Blackwell RE; Caldwell B; Chang RJ; Jaffe R; Joplin G; Robbins RJ; Tyson J; Thorner MO
J Clin Endocrinol Metab; 1985 Apr; 60(4):698-705. PubMed ID: 3882737
[TBL] [Abstract][Full Text] [Related]
20. The medical treatment of the hypersecreting pituitary gland.
Corenblum B
Can J Neurol Sci; 1985 Aug; 12(3):243-50. PubMed ID: 2996735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
